{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T05:09:56Z","timestamp":1768280996395,"version":"3.49.0"},"reference-count":129,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1016\/j.ijantimicag.2010.11.027","type":"journal-article","created":{"date-parts":[[2011,1,27]],"date-time":"2011-01-27T09:25:30Z","timestamp":1296120330000},"page":"396-404","source":"Crossref","is-referenced-by-count":63,"title":["Immunoglobulin treatment in primary antibody deficiency"],"prefix":"10.1016","volume":"37","author":[{"given":"L.J.","family":"Maarschalk-Ellerbroek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.M.","family":"Hoepelman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.M.","family":"Ellerbroek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0005","doi-asserted-by":"crossref","first-page":"16","DOI":"10.4065\/84.1.16","article-title":"Incidence and temporal trends of primary immunodeficiency: a population-based cohort study","volume":"84","author":"Joshi","year":"2009","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0010","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/qjmed\/95.10.655","article-title":"Common variable immune deficiency: respiratory manifestations, pulmonary function and high-resolution CT scan findings","volume":"95","author":"Thickett","year":"2002","journal-title":"QJM"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0015","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1006\/clim.1999.4725","article-title":"Common variable immunodeficiency: clinical and immunological features of 248 patients","volume":"92","author":"Cunningham-Rundles","year":"1999","journal-title":"Clin Immunol"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0020","first-page":"199","article-title":"Cellular abnormalities in common variable immunodeficiency","volume":"2","author":"Spickett","year":"1990","journal-title":"Immunodefic Rev"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0025","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.jaci.2006.01.038","article-title":"Molecular basis of common variable immunodeficiency","volume":"117","author":"Castigli","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0030","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1172\/JCI39748","article-title":"CD81 gene defect in humans disrupts CD19 complex formation and leads to antibody deficiency","volume":"120","author":"van Zelm","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0035","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1172\/JCI40231","article-title":"CD20 deficiency in humans results in impaired T cell-independent antibody responses","volume":"120","author":"Kuijpers","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0040","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1046\/j.1365-2249.2000.01239.x","article-title":"Enhanced apoptosis of T cells in common variable immunodeficiency (CVID): role of defective CD28 co-stimulation","volume":"120","author":"Di Renzo","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0045","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1542\/peds.9.6.722","article-title":"Agammaglobulinemia","volume":"9","author":"Bruton","year":"1952","journal-title":"Pediatrics"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0050","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00005792-199611000-00001","article-title":"X-linked agammaglobulinemia. A clinical and molecular analysis","volume":"75","author":"Ochs","year":"1996","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0055","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1067\/mai.2002.122466","article-title":"Primary immunodeficiency disorders: antibody deficiency","volume":"109","author":"Ballow","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0060","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1056\/NEJM197706302962601","article-title":"Persistent and fatal central-nervous-system ECHOvirus infections in patients with agammaglobulinemia","volume":"296","author":"Wilfert","year":"1977","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1053\/jinf.2002.1066","article-title":"Enteroviral infections in primary immunodeficiency (PID): a survey of morbidity and mortality","volume":"46","author":"Halliday","year":"2003","journal-title":"J Infect"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0070","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1006\/clim.2002.5241","article-title":"Clinical, immunological, and molecular analysis in a large cohort of patients with X-linked agammaglobulinemia: an Italian multicenter study","volume":"104","author":"Plebani","year":"2002","journal-title":"Clin Immunol"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0075","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/01.md.0000229482.27398.ad","article-title":"X-linked agammaglobulinemia: report on a United States registry of 201 patients","volume":"85","author":"Winkelstein","year":"2006","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0080","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1046\/j.1365-2249.2003.02253.x","article-title":"Lymphoproliferative disease in antibody deficiency: a multi-centre study","volume":"134","author":"Gompels","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0085","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1097\/00042737-200012090-00013","article-title":"Gastric adenocarcinoma in a patient with X-linked agammaglobulinaemia","volume":"12","author":"Bachmeyer","year":"2000","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0090","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1002\/1097-0142(19930901)72:5<1528::AID-CNCR2820720506>3.0.CO;2-V","article-title":"X-linked agammaglobulinemia and gastric adenocarcinoma","volume":"72","author":"Lavilla","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0095","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/0140-6736(93)90883-I","article-title":"Colorectal cancer in patients with X-linked agammaglobulinaemia","volume":"341","author":"van der Meer","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0100","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1097\/00008480-199312000-00010","article-title":"Clinical significance of IgG subclasses","volume":"5","author":"Herrod","year":"1993","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0105","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1203\/00006450-199001000-00004","article-title":"Clinical and immunologic characteristics of healthy children with subnormal serum concentrations of IgG2","volume":"27","author":"Shackelford","year":"1990","journal-title":"Pediatr Res"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0110","first-page":"280","article-title":"Immunoglobulin G subclasses in immunodeficiency","volume":"19","author":"Soderstrom","year":"1987","journal-title":"Ann Clin Res"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0115","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1056\/NEJM198703263161306","article-title":"An immunodeficiency characterized by impaired antibody responses to polysaccharides","volume":"316","author":"Ambrosino","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0120","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/0091-6749(88)90887-1","article-title":"Selective defect in the antibody response to Haemophilus influenzae type b in children with recurrent infections and normal serum IgG subclass levels","volume":"81","author":"Ambrosino","year":"1988","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0125","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S1081-1206(10)60035-X","article-title":"Preimmunization and postimmunization pneumococcal antibody titers in children with recurrent infections","volume":"76","author":"Hidalgo","year":"1996","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0130","first-page":"125","article-title":"Selective deficiency in pneumococcal antibody response in children with recurrent infections","volume":"75","author":"Epstein","year":"1995","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0135","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3109\/00365549709011838","article-title":"Immunoglobulin deficiencies and impaired immune response to polysaccharide antigens in adult patients with recurrent community-acquired pneumonia","volume":"29","author":"Ekdahl","year":"1997","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0140","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1136\/pgmj.2003.012443","article-title":"Echocardiographic abnormalities in primary antibody deficiency","volume":"80","author":"Johnston","year":"2004","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0145","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1136\/jcp.2004.016204","article-title":"Primary antibody deficiency and diagnostic delay","volume":"58","author":"Seymour","year":"2005","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0150","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S0091-6749(99)70085-0","article-title":"Pulmonary abnormalities in patients with primary hypogammaglobulinemia","volume":"104","author":"Kainulainen","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0155","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1136\/bmj.298.6672.516","article-title":"Primary antibody deficiency and diagnostic delay","volume":"298","author":"Blore","year":"1989","journal-title":"BMJ"},{"issue":"2 Suppl.","key":"10.1016\/j.ijantimicag.2010.11.027_bib0160","doi-asserted-by":"crossref","first-page":"7S","DOI":"10.1007\/BF00918361","article-title":"Individual patient variations in the kinetics of intravenous immune globulin administration","volume":"2","author":"Pirofsky","year":"1982","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0165","first-page":"1","article-title":"Comparison of the clinical efficacy and safety of an intramuscular and an intravenous immunoglobulin preparation for replacement therapy in idiopathic adult onset panhypogammaglobulinaemia","volume":"76","author":"Garbett","year":"1989","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0170","doi-asserted-by":"crossref","first-page":"55","DOI":"10.7326\/0003-4819-93-1-55","article-title":"Immunoglobulin replacement therapy by slow subcutaneous infusion","volume":"93","author":"Berger","year":"1980","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0175","first-page":"689","article-title":"Home treatment in patients with antibody deficiency by slow subcutaneous infusion of gammaglobulin","volume":"1","author":"Roord","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0180","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s10875-006-9002-x","article-title":"Rapid subcutaneous IgG replacement therapy is effective and safe in children and adults with primary immunodeficiencies\u2014a prospective, multi-national study","volume":"26","author":"Gardulf","year":"2006","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0185","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/0140-6736(91)90147-H","article-title":"Home treatment of hypogammaglobulinaemia with subcutaneous gammaglobulin by rapid infusion","volume":"338","author":"Gardulf","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0190","first-page":"81","article-title":"Safety of rapid subcutaneous gammaglobulin infusions in patients with primary antibody deficiency","volume":"4","author":"Gardulf","year":"1993","journal-title":"Immunodeficiency"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0195","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0140-6736(95)90346-1","article-title":"Subcutaneous immunoglobulin replacement in patients with primary antibody deficiencies: safety and costs","volume":"345","author":"Gardulf","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0200","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1056\/NEJM199412153312402","article-title":"Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin","volume":"331","author":"Bjoro","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0205","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0002-9343(88)90016-2","article-title":"Intravenous immunoglobulin prophylaxis causing liver damage in 16 of 77 patients with hypogammaglobulinemia or IgG subclass deficiency","volume":"84","author":"Bj\u00f6rkander","year":"1988","journal-title":"Am J Med"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0210","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0149-2918(96)80200-1","article-title":"Intravenous immunoglobulin and hepatitis C virus: the British episode","volume":"18","author":"Healey","year":"1996","journal-title":"Clin Ther"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0215","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0149-2918(96)80202-5","article-title":"Intravenous immunoglobulin and hepatitis C virus: the Boston episode","volume":"18","author":"Schneider","year":"1996","journal-title":"Clin Ther"},{"issue":"Suppl. 15","key":"10.1016\/j.ijantimicag.2010.11.027_bib0220","first-page":"S47","article-title":"Virus validation studies of immunoglobulin preparations","volume":"14","author":"Biesert","year":"1996","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0225","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/BF00915424","article-title":"Immunoglobulin A concentrations in commercial immune globulins","volume":"7","author":"Apfelzweig","year":"1987","journal-title":"J Clin Immunol"},{"issue":"5 Suppl.","key":"10.1016\/j.ijantimicag.2010.11.027_bib0230","first-page":"S43","article-title":"Differences among available immunoglobulin preparations for intravenous use","volume":"7","author":"Skvaril","year":"1988","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0235","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1365-2249.2007.03432.x","article-title":"Recognition, clinical diagnosis and management of patients with primary antibody deficiencies: a systematic review","volume":"149","author":"Wood","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0240","first-page":"31","article-title":"Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications","volume":"86","author":"Hermaszewski","year":"1993","journal-title":"QJ Med"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0245","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/00005792-198505000-00001","article-title":"X-linked agammaglobulinemia: an analysis of 96 patients","volume":"64","author":"Lederman","year":"1985","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0250","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1182\/blood-2007-11-124545","article-title":"Common variable immunodeficiency disorders: division into distinct clinical phenotypes","volume":"112","author":"Chapel","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0255","first-page":"237","article-title":"Intravenous immunoglobulin therapy for antibody deficiency","volume":"36","author":"Nolte","year":"1979","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0260","doi-asserted-by":"crossref","first-page":"435","DOI":"10.7326\/0003-4819-101-4-435","article-title":"Efficacy of intravenous immunoglobulin in primary humoral immunodeficiency disease","volume":"101","author":"Cunningham-Rundles","year":"1984","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0265","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0002-9343(85)90006-3","article-title":"Benefit of intravenous IgG replacement in hypogammaglobulinemic patients with chronic sinopulmonary disease","volume":"79","author":"Roifman","year":"1985","journal-title":"Am J Med"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0270","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0090-1229(87)90123-1","article-title":"Results of a prospective controlled two-dose crossover study with intravenous immunoglobulin and comparison (retrospective) with plasma treatment","volume":"43","author":"Bernatowska","year":"1987","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0275","first-page":"147","article-title":"Treatment with gammaglobulin preparation for intravenous use in children with humoral immunodeficiency: clinical and immunologic follow-up","volume":"64","author":"Galli","year":"1990","journal-title":"Ann Allergy"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0280","first-page":"335","article-title":"High- vs low-dose immunoglobulin therapy in the long-term treatment of X-linked agammaglobulinemia","volume":"146","author":"Liese","year":"1992","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0285","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0022-3476(99)70246-5","article-title":"Early and prolonged intravenous immunoglobulin replacement therapy in childhood agammaglobulinemia: a retrospective survey of 31 patients","volume":"134","author":"Quartier","year":"1999","journal-title":"J Pediatr"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0290","doi-asserted-by":"crossref","first-page":"165","DOI":"10.7326\/0003-4819-135-3-200108070-00008","article-title":"The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia. A randomized, double-blind, multicenter crossover trial","volume":"135","author":"Eijkhout","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0295","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1053\/rmed.2000.1020","article-title":"Respiratory disorders in common variable immunodeficiency","volume":"95","author":"Mart\u00ednez Garc\u00eda","year":"2001","journal-title":"Respir Med"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0300","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1067\/mai.2002.124999","article-title":"Efficacy of intravenous immunoglobulin in the prevention of pneumonia in patients with common variable immunodeficiency","volume":"109","author":"Busse","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0305","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.intimp.2004.02.011","article-title":"Immunoglobulin therapy to control lung damage in patients with common variable immunodeficiency","volume":"4","author":"de Gracia","year":"2004","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0310","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0928-8244(03)00304-3","article-title":"Efficacy of intravenous immunoglobulin on the prevention of pneumonia in patients with agammaglobulinemia","volume":"40","author":"Aghamohammadi","year":"2004","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0315","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1398-9995.2005.00756.x","article-title":"Intravenous immunoglobulin replacement prevents severe and lower respiratory tract infections, but not upper respiratory tract and non-respiratory infections in common variable immune deficiency","volume":"60","author":"Favre","year":"2005","journal-title":"Allergy"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0320","first-page":"239","article-title":"The efficacy of immunoglobulin replacement therapy in the long-term follow-up of the B-cell deficiencies (XLA, HIM, CVID)","volume":"47","author":"Bayrakci","year":"2005","journal-title":"Turk J Pediatr"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0325","first-page":"114","article-title":"Effect of regular intravenous immunoglobulin therapy on prevention of pneumonia in patients with common variable immunodeficiency","volume":"39","author":"Pourpak","year":"2006","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0330","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1080\/00365540600951192","article-title":"Immunoglobulin prophylaxis in 350 adults with IgG subclass deficiency and recurrent respiratory tract infections: a long-term follow-up","volume":"39","author":"Olinder-Nielsen","year":"2007","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0335","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1159\/000199723","article-title":"Efficacy of intravenous gammaglobulin for immunoglobulin G subclass and\/or antibody deficiency in adults","volume":"149","author":"Abdou","year":"2009","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0340","first-page":"283","article-title":"Evaluation of postimmunization pneumococcal titers in children with recurrent infections and normal levels of immunoglobulin","volume":"70","author":"Zora","year":"1993","journal-title":"Ann Allergy"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0345","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.jaci.2010.02.040","article-title":"Infection outcomes in patients with common variable immunodeficiency disorders: relationship to immunoglobulin therapy over 22 years","volume":"125","author":"Lucas","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0350","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s10875-007-9075-1","article-title":"Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency","volume":"27","author":"Quinti","year":"2007","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0355","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1097\/00000478-199610000-00010","article-title":"Gastrointestinal pathology in patients with common variable immunodeficiency and X-linked agammaglobulinemia","volume":"20","author":"Washington","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0360","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s11894-004-0053-y","article-title":"Common variable immunodeficiency and the gastrointestinal tract","volume":"6","author":"Kalha","year":"2004","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0365","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1097\/PAS.0b013e3180cab60c","article-title":"Gastrointestinal tract pathology in patients with common variable immunodeficiency (CVID): a clinicopathologic study and review","volume":"31","author":"Daniels","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0370","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1007\/s10620-006-9736-6","article-title":"Gastrointestinal manifestations in patients with common variable immunodeficiency","volume":"52","author":"Khodadad","year":"2007","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0375","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1053\/j.gastro.2006.06.022","article-title":"Excess IL-12 but not IL-23 accompanies the inflammatory bowel disease associated with common variable immunodeficiency","volume":"131","author":"Mannon","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0380","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.jaci.2009.06.018","article-title":"Pathogenesis and treatment of gastrointestinal disease in antibody deficiency syndromes","volume":"124","author":"Agarwal","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0385","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1136\/pgmj.75.881.161","article-title":"Primary antibody deficiency and Crohn's disease","volume":"75","author":"Conlong","year":"1999","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0390","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1038\/ajg.2010.214","article-title":"The enteropathy associated with common variable immunodeficiency: the delineated frontiers with celiac disease","volume":"105","author":"Malamut","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0395","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.iac.2008.01.008","article-title":"Principles of and advances in immunoglobulin replacement therapy for primary immunodeficiency","volume":"28","author":"Berger","year":"2008","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0400","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1159\/000135694","article-title":"Progression of selective IgA deficiency to common variable immunodeficiency","volume":"147","author":"Aghamohammadi","year":"2008","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0405","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/00006454-199808000-00005","article-title":"Response to a heptavalent conjugate Streptococcus pneumoniae vaccine in children with recurrent infections who are unresponsive to the polysaccharide vaccine","volume":"17","author":"Sorensen","year":"1998","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0410","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0002-9343(84)90320-6","article-title":"Intravenous immune globulin therapy in hypogammaglobulinemia. A review","volume":"76","author":"Pirofsky","year":"1984","journal-title":"Am J Med"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0415","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1056\/NEJM199107113250207","article-title":"The use of intravenous immune globulin in immunodeficiency diseases","volume":"325","author":"Buckley","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0420","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.iac.2008.07.002","article-title":"Subcutaneous administration of IgG","volume":"28","author":"Berger","year":"2008","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0425","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s10875-006-9021-7","article-title":"Safety and efficacy of self-administered subcutaneous immunoglobulin in patients with primary immunodeficiency diseases","volume":"26","author":"Ochs","year":"2006","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0430","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1023\/A:1006678312925","article-title":"The comparison of the efficacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapy","volume":"20","author":"Chapel","year":"2000","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0435","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/S0140-6736(88)90614-9","article-title":"Home intravenous immunoglobulin therapy","volume":"2","author":"Chapel","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0440","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S0140-6736(86)92826-6","article-title":"Intravenous immunoglobulin home treatment for patients with primary immunodeficiency diseases","volume":"1","author":"Ochs","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0445","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/BF00917331","article-title":"Home intravenous immunoglobulin therapy by self-administration","volume":"6","author":"Ashida","year":"1986","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0450","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.intimp.2005.11.003","article-title":"Differences between IGIV products: impact on clinical outcome","volume":"6","author":"Gelfand","year":"2006","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0455","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s10875-008-9231-2","article-title":"Safety and efficacy of Privigen, a novel 10% liquid immunoglobulin preparation for intravenous use, in patients with primary immunodeficiencies","volume":"29","author":"Stein","year":"2009","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0460","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2165\/00002018-199921030-00003","article-title":"Adverse effects of intravenous immunoglobulin therapy","volume":"21","author":"Nydegger","year":"1999","journal-title":"Drug Saf"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0465","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0272-6386(96)90505-3","article-title":"Osmotic nephrosis due to high-dose immunoglobulin therapy containing sucrose (but not with glycine) in a patient with immunoglobulin A nephritis","volume":"28","author":"Hansen-Schmidt","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0470","first-page":"213","article-title":"Substitution therapy in immunodeficient patients with anti-IgA antibodies or severe adverse reactions to previous immunoglobulin therapy","volume":"61","author":"Eijkhout","year":"2003","journal-title":"Neth J Med"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0475","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.clim.2006.10.002","article-title":"Anti-IgA antibodies in common variable immunodeficiency (CVID): diagnostic workup and therapeutic strategy","volume":"122","author":"Horn","year":"2007","journal-title":"Clin Immunol"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0480","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1046\/j.1365-2249.1998.00571.x","article-title":"Induction of unresponsiveness against IgA in IgA-deficient patients on subcutaneous immunoglobulin infusion therapy","volume":"112","author":"Sundin","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0485","first-page":"634","article-title":"The half-lives of IgG subclasses and specific antibodies in patients with primary immunodeficiency who are receiving intravenously administered immunoglobulin","volume":"112","author":"Mankarious","year":"1988","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0490","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1592\/phco.26.6.813","article-title":"Pharmacokinetics of intravenous immunoglobulin: a systematic review","volume":"26","author":"Koleba","year":"2006","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0495","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/BF00918706","article-title":"Alterations in the half-life and clearance of IgG during therapy with intravenous gamma-globulin in 16 patients with severe primary humoral immunodeficiency","volume":"6","author":"Schiff","year":"1986","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0500","first-page":"225","article-title":"Survival of antigen-specific antibody following administration of intravenous immunoglobulin in patients with primary immunodeficiency diseases","volume":"23","author":"Fischer","year":"1988","journal-title":"Monogr Allergy"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0505","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/0002-9343(84)90324-3","article-title":"Comparison of high-dose and low-dose intravenous immunoglobulin therapy in patients with primary immunodeficiency diseases","volume":"76","author":"Ochs","year":"1984","journal-title":"Am J Med"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0510","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0140-6736(87)90494-6","article-title":"High-dose versus low-dose intravenous immunoglobulin in hypogammaglobulinaemia and chronic lung disease","volume":"1","author":"Roifman","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0515","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.clim.2010.06.012","article-title":"Impact of trough IgG on pneumonia incidence in primary immunodeficiency: a meta-analysis of clinical studies","volume":"137","author":"Orange","year":"2010","journal-title":"Clin Immunol"},{"issue":"4 Suppl.","key":"10.1016\/j.ijantimicag.2010.11.027_bib0520","doi-asserted-by":"crossref","first-page":"S525","DOI":"10.1016\/j.jaci.2006.01.015","article-title":"Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology","volume":"117","author":"Orange","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0525","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0002-9343(84)90323-1","article-title":"Use of intravenous immune globulin in pregnant women with common variable hypogammaglobulinemia","volume":"76","author":"Sorensen","year":"1984","journal-title":"Am J Med"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0530","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/0020-7292(82)90008-X","article-title":"Hypogammaglobulinaemia during pregnancy in identical twin sisters","volume":"20","author":"Amarin","year":"1982","journal-title":"Int J Gynaecol Obstet"},{"issue":"3 Suppl.","key":"10.1016\/j.ijantimicag.2010.11.027_bib0535","first-page":"39S","article-title":"Intravenous immunoglobulin in pregnancy","volume":"66","author":"Smith","year":"1985","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0540","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/ajh.2830210313","article-title":"Common variable hypogammaglobulinemia in pregnancy: treatment with high-dose immunoglobulin infusions","volume":"21","author":"Madsen","year":"1986","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0545","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/BF01720276","article-title":"IgG replacement therapy for primary hypogammaglobulinaemia during pregnancy: report of 9 pregnancies in 4 patients","volume":"60","author":"Williams","year":"1990","journal-title":"Blut"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0550","first-page":"114","article-title":"Intravenous gamma globulin administration to common variable immunodeficient women during pregnancy: case report and review of the literature","volume":"14","author":"Schaffer","year":"1994","journal-title":"J Perinatol"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0555","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1023\/A:1011051704960","article-title":"Rapid subcutaneous IgG replacement therapy at home for pregnant immunodeficient women","volume":"21","author":"Gardulf","year":"2001","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0560","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1056\/NEJM198602273140907","article-title":"Anaphylactic reactions after gamma globulin administration in patients with hypogammaglobulinemia. Detection of IgE antibodies to IgA","volume":"314","author":"Burks","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0565","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1046\/j.1365-2249.2003.02199.x","article-title":"Prospective audit of adverse reactions occurring in 459 primary antibody-deficient patients receiving intravenous immunoglobulin","volume":"133","author":"Brennan","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0570","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S1081-1206(10)61711-5","article-title":"Adverse reactions of prophylactic intravenous immunoglobulin infusions in Iranian patients with primary immunodeficiency","volume":"92","author":"Aghamohammadi","year":"2004","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0575","doi-asserted-by":"crossref","first-page":"259","DOI":"10.7326\/0003-4819-121-4-199408150-00004","article-title":"Aseptic meningitis associated with high-dose intravenous immunoglobulin therapy: frequency and risk factors","volume":"121","author":"Sekul","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0580","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1212\/WNL.47.3.674","article-title":"Complications of intravenous immune globulin treatment in neurologic disease","volume":"47","author":"Brannagan","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0585","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.intimp.2005.11.015","article-title":"Adverse events associated with intravenous immunoglobulin therapy","volume":"6","author":"Hamrock","year":"2006","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0590","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1191\/0961203303lu2168rr","article-title":"Review: intravenous immunoglobulin therapy and thromboembolic complications","volume":"14","author":"Katz","year":"2005","journal-title":"Lupus"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0595","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1212\/01.WNL.0000068335.01620.9D","article-title":"The clinical features of 16 cases of stroke associated with administration of IVIg","volume":"60","author":"Caress","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0600","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1006\/clim.2001.5140","article-title":"Progressive neurodegeneration in patients with primary immunodeficiency disease on IVIG treatment","volume":"102","author":"Ziegner","year":"2002","journal-title":"Clin Immunol"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0605","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1097\/00006454-199409000-00012","article-title":"Mechanisms of action of intravenous immune serum globulin therapy","volume":"13","author":"Ballow","year":"1994","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0610","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1046\/j.1365-2141.2001.02742.x","article-title":"Incidence and associations of acute renal failure complicating high-dose intravenous immunoglobulin therapy","volume":"113","author":"Sati","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0615","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/j.1875-9114.1995.tb02894.x","article-title":"Acute renal failure after administration of intravenous immunoglobulin: review of the literature and case report","volume":"15","author":"Winward","year":"1995","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0620","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/00045391-199811000-00008","article-title":"Acute renal failure and intravenous immune globulin: sucrose nephropathy in disguise?","volume":"5","author":"Perazella","year":"1998","journal-title":"Am J Ther"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0625","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clim.2004.02.002","article-title":"Subcutaneous immunoglobulin replacement in primary immunodeficiencies","volume":"112","author":"Berger","year":"2004","journal-title":"Clin Immunol"},{"issue":"5 Suppl. 1","key":"10.1016\/j.ijantimicag.2010.11.027_bib0630","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S1081-1206(10)61142-8","article-title":"Practice parameter for the diagnosis and management of primary immunodeficiency","volume":"94","author":"Bonilla","year":"2005","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0635","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1164\/ajrccm.162.2.9910086","article-title":"Tobramycin solution for inhalation reduces sputum Pseudomonas aeruginosa density in bronchiectasis","volume":"162","author":"Barker","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0640","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0022-3565(24)35272-3","article-title":"Anti-inflammatory activity of macrolide antibiotics","volume":"292","author":"Ianaro","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.ijantimicag.2010.11.027_bib0645","first-page":"CD000996","article-title":"Inhaled steroids for bronchiectasis","author":"Kolbe","year":"2000","journal-title":"Cochrane Database Syst Rev"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857910005534?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857910005534?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,2]],"date-time":"2025-03-02T05:44:31Z","timestamp":1740894271000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857910005534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":129,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S0924857910005534"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2010.11.027","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}